Digest Réseau Comment ça marche
Réseau
/
Sociétés
He
Non vérifié

Helsinn Healthcare S.A.

Ce que nous écrivons

Annonces ÉconomiquesIndustrie pharmaceutiquePublicité/Marketing/Médias/Communication

8 communiqués de presse

Voir tous les communiqués de presse
25/02/2026
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn Healthcare & InVirtuoLabs sign a Strategic Collaboration in AI-Driven Drug Discovery
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
18/02/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Helsinn announces European Commission approval of AKYNZEO® Oral Suspension
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
11/02/2026
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn and MagnaPharm enter long-term agreement for AKYNZEO® and ALOXI® across five Central and Eastern European countries
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
09/02/2026
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn and ESTEVE expand their partnership extending the Distribution and Licence Agreement for AKYNZEO® and ALOXI® to Austria
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
12/01/2026
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn announces new Executive Leadership Team as it celebrates 50 years
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
17/10/2025
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
AKYNZEO® demonstrates superior prevention of chemotherapy-induced nausea and vomiting compared to the standard of care in patients receiving moderately emetogenic chemotherapy with additional predictive factors
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
02/04/2025
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0
08/01/2025
Industrie pharmaceutique
Publicité/Marketing/Médias/Communication
Annonces Économiques
Helsinn Group and ESTEVE sign a partnership agreement renewal to commercialize AKYNZEO® and ALOXI® in Germany
Source
Helsinn Healthcare S.A.
Émetteur
GLOBENEWSWIRE
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0